Xavier Amador
Affiliations: | Columbia University, New York, NY |
Area:
Clinical Psychology, Law, Criminology and PenologyGoogle:
"Xavier Amador"Children
Sign in to add traineeSari Trungold | grad student | 2000 | Columbia |
Erin L. Olivo | grad student | 2001 | Columbia |
Andrew A. Shiva | grad student | 2001 | Columbia |
Ricardo F. Hornos | grad student | 2002 | Columbia |
Lisa J. Kohl | grad student | 2003 | Columbia |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Amador X. (2023) Denial of anosognosia in schizophrenia. Schizophrenia Research. 252: 242-243 |
Michel P, Baumstarck K, Auquier P, et al. (2013) Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia. Bmc Psychiatry. 13: 229 |
Amador X. (2012) Poor insight in schizophrenia: implications for diagnosis and treatment. Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 27: 320-2 |
Arango C, Amador X. (2011) Lessons learned about poor insight. Schizophrenia Bulletin. 37: 27-8 |
Goetz RR, Corcoran C, Yale S, et al. (2007) Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS). Schizophrenia Research. 93: 169-77 |
Pompili M, Amador XF, Girardi P, et al. (2007) Suicide risk in schizophrenia: learning from the past to change the future. Annals of General Psychiatry. 6: 10 |
Gharabawi GM, Lasser RA, Bossie CA, et al. (2006) Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. International Clinical Psychopharmacology. 21: 233-40 |
Brébion G, Gorman JM, Malaspina D, et al. (2005) A model of verbal memory impairments in schizophrenia: two systems and their associations with underlying cognitive processes and clinical symptoms. Psychological Medicine. 35: 133-42 |
Bourgeois M, Swendsen J, Young F, et al. (2004) Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. The American Journal of Psychiatry. 161: 1494-6 |
Brébion G, Bressan RA, Amador X, et al. (2004) Medications and verbal memory impairment in schizophrenia: The role of anticholinergic drugs Psychological Medicine. 34: 369-374 |